Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Structural Modification In Supraglottic Airway Device

NCT: NCT04498598 · RECRUITING

NCT IDNCT04498598
StatusRECRUITING
Start Date2020-09-30
Completion2026-08-24

Brief Summary

The proposed A/Z modification of a supraglottic airway (SGA) incorporates an opening in the SGA body that enables access to the endotracheal tube (ETT) through the body of the SGA without the need of using an exchange catheter, thus enabling an ETT to move in the body of the SGA and convert a supraglottic to endotracheal ventilation. In its original form an adaptor made from same material currently used in the endotracheal tubes can make ventilation through the proposed airway device possible in exactly the same manner of a conventional SGA currently used. This adapter also known as the R-piece can be replaced with an ETT. The modification also allows placement of SGA over an existing ETT to convert and endotracheal (ET) to supraglottic (SG) mode of ventilation without the need to use an exchange catheter.

Frequently Asked Questions

What is Structural Modification In Supraglottic Airway Device?

Structural Modification In Supraglottic Airway Device is a clinical trial registered under NCT04498598. Current status: RECRUITING.

What is the status of NCT04498598?

The current status of NCT04498598 (Structural Modification In Supraglottic Airway Device) is: RECRUITING.

When did Structural Modification In Supraglottic Airway Device start?

Structural Modification In Supraglottic Airway Device started on 2020-09-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.